<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: institute of mental health</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'institute of mental health'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22institute+of+mental+health%22&t=%22institute+of+mental+health%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:34:31 +0100</lastBuildDate>
        <item>
            <title>Stanford, Taxpayer-Funded Research &amp; Disclosures</title>
            <link>http://www.medworm.com/index.php?rid=4343331&amp;cid=t_230599_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FMzN0NGIvnh4%2F</link>
            <description>In 2008, the US Senate Finance Committee charged that Stanford University failed to properly monitor alleged conflicts of interest involving Alan Schatzberg, the former chair of its psychiatry department, who owned a substantive amount of stock in Corcept Therapeutics, which was studying the development of mifepristone, or RU-486, for treating psychiatric depression. Beyond his stock holdings, Schatzberg was also listed as a co-patent holder for the drug, which is best known for inducing abortion, and he received a grant from the National Institutes of Health to oversee the research.
The allegation was part of a lengthy probe into the wider issue of taxpayer-funded research and undisclosed and unmonitored conflicts involving universities, academic researchers and the pharmaceutical industr...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4343331</comments>
            <pubDate>Thu, 13 Jan 2011 14:26:00 +0100</pubDate>
            <guid isPermaLink="false">4343331</guid>        </item>
        <item>
            <title>Tufts University And Its Selective List Of Speakers</title>
            <link>http://www.medworm.com/index.php?rid=3823160&amp;cid=t_230599_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FtzsBy8SMXoI%2F</link>
            <description>Early last year, a stink arose at Tufts University when top university officials refused to allow other administrators to be panelists at a conference on conflicts of interest in medicine and research because Paul Thacker, an aide to US Senator Chuck Grassley, was due to give the keynote speech. Why? They were uncomfortable that Grassley was investigating ties between a Tufts professor and drugmakers (back story here and here).
In the same time period, however, one subject of the ongoing Grassley probe did speak at Tufts. According to disclosure forms filed with his employer, Charles Nemeroff, who is now psychiatry chair at the University of Miami Miller School of Medicine, gave a lecture at Tufts sometime between June 1, 2009 and May 31, 2010. He was paid between $1,000 and $5,500, but th...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3823160</comments>
            <pubDate>Wed, 04 Aug 2010 14:09:54 +0100</pubDate>
            <guid isPermaLink="false">3823160</guid>        </item>
        <item>
            <title>Grassley Probes Nemeroff And University Of Miami</title>
            <link>http://www.medworm.com/index.php?rid=3641321&amp;cid=t_230599_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FrYivhU7sae4%2F</link>
            <description>The Charles Nemeroff affair encompasses more people all the time. Now, the University of Miami Medical School has become ensnared in the ongoing probe launched by US Senator Chuck Grassley, who investigated Nemeroff as part of an inquiry into undisclosed financial conflicts of intereest among academic researchers who receive federal grants.
You may recall Nemeroff, who was recently hired by the University of Miami, had departed Emory University after the Senate probe disclosed he was accepting sizeable consulting fees from GlaxoSmithKline at the same time he was the primary investigator on an NIH-funded grant for research into a Glaxo drug (see this). Before his departure, Emory imposed a two-year ban on grants for on Nemeroff. This week, however, the U of Miami med school head, Pascal Gol...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3641321</comments>
            <pubDate>Tue, 08 Jun 2010 15:44:41 +0100</pubDate>
            <guid isPermaLink="false">3641321</guid>        </item>
        <item>
            <title>Can The NIH Really Monitor Conflicts Of Interest?</title>
            <link>http://www.medworm.com/index.php?rid=3636020&amp;cid=t_230599_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fey5jUPYG6Hs%2F</link>
            <description>For the past two years, the National Institutes of Health has been pressured by Congress to do a better job of monitoring conflicts of interest in which academic researchers accept funding from the agency and drugmakers. At issue is the concern that key research and subsequent studies will unduly influence treatment, and so the NIH recenty proposed tougher rules (see this).
Earlier this year, the US Senate Finance Committee extended its scrutiny to Tom Insel, the director of the National Institutes of Mental Health (see photo), given that many conflicts involved academic psychiatrists and drugmakers that market antidepressants and antipsychotics (see this). Now, The Chronicle of Higher Education peels back an interesting, long-running relationship between Insel and one of the more notoriou...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3636020</comments>
            <pubDate>Mon, 07 Jun 2010 13:21:25 +0100</pubDate>
            <guid isPermaLink="false">3636020</guid>        </item>
        <item>
            <title>Mental Health Statistics</title>
            <link>http://www.medworm.com/index.php?rid=3526797&amp;cid=t_230599_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F05%2F03%2Fmental-health-statistics%2F</link>
            <description>May is Mental Health Month again, so it&amp;#8217;s also a good time to review the mental health statistics behind mental illness. Some of the statistics going around aren&amp;#8217;t entirely accurate, because they&amp;#8217;re based upon outdated web pages on the National Institute of Mental Health (NIMH) website. This misinformation is then propagated by well-meaning people and organizations, including NAMI and others. Sadly, the NIMH website is not as accurate or up-to-date as people like to think it is (I think that because it&amp;#8217;s a government resource, people just assume it&amp;#8217;s accurate and correct).
For instance, the NIMH Statistics page puts data into context of 2004 Census data. Well, it&amp;#8217;s 2010, not 2004, and we have more up-to-date Census data. Also according to the more recent...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3526797</comments>
            <pubDate>Mon, 03 May 2010 14:45:34 +0100</pubDate>
            <guid isPermaLink="false">3526797</guid>        </item>
        <item>
            <title>Talk Is Not Cheap: NPR Host Has Ties To Pharma</title>
            <link>http://www.medworm.com/index.php?rid=1975631&amp;cid=t_230599_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F460224952%2F</link>
            <description>Last May, National Public Radio talk-show host Fred Goodwin was, himself, the subject of a great deal of chatter. An episode of his program, &amp;#8220;The Infinite Mind,&amp;#8221; which is heard on 300 NPR stations, featured three experts who discussed the controversial link between antidepressants and suicide. And all four, including Goodwin, declared that worries about the drugs have been overblown (back story).
But there was a catch: Goodwin never pointed out that all three guests had ties to pharma, or that the show received &amp;#8220;unrestricted&amp;#8221; from drugmakers, including Lilly, which sells Prozac and Cymbalta. The segment, by the way, aired just two months after UK regulators concluded a four-year investigation of Glaxo&amp;#8217;s Paxil and found the drugmaker had been aware since 1998 t...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1975631</comments>
            <pubDate>Fri, 21 Nov 2008 03:25:45 +0100</pubDate>
            <guid isPermaLink="false">1975631</guid>        </item>
        <item>
            <title>DEPRESSION: Out of the Shadows</title>
            <link>http://www.medworm.com/index.php?rid=4060722&amp;cid=t_230599_109_f&amp;fid=34859&amp;url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2008%2F05%2Fdepression_out_of_the_shadows.php</link>
            <description>This looks like a good one. I'm going to watch for sure. You can even buy the DVD now.

&quot;DEPRESSION: Out of the Shadows is a 90-minute documentary about recognizing, treating, and researching depression.



DEPRESSION: Out of the Shadows . Video Preview | PBS

A lot of Americans are keeping an important, possibly deadly secret.

The National Institute of Mental Health reports that approximately 18.8 million American adults have a depressive disorder. The disease is not discriminating, seeping into all age, race, gender, and socioeconomic groups. Depression stalls careers, strains relationships, and sometimes ends lives.

So if this many people are living with the disease, why the silence? DEPRESSION: Out of the Shadows is a multi-dimensional PBS project that explores the disease's complex ...</description>
            <author>Ψ Dare To Dream...</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4060722</comments>
            <pubDate>Thu, 15 May 2008 02:22:22 +0100</pubDate>
            <guid isPermaLink="false">4060722</guid>        </item>
        <item>
            <title>January 4th is Friday—-Responses to the NIMH’s Request for Information about Autism Research Priorities is Due</title>
            <link>http://www.medworm.com/index.php?rid=1124278&amp;cid=t_230599_133_f&amp;fid=35096&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2F209474550%2F</link>
            <description>What better way to start the new year than making your voice heard to the National Institute of Mental Health (NIMH) about research priorities for the Interagency Autism Coordinating Committee Strategic Plan for Autism Spectrum Disorders (ASD)?


You can contact the NIMH with your suggestions in response to a Request for Information (RFI): Research Priorities for the Interagency Autism Coordinating Committee Strategic Plan for Autism Spectrum Disorders (ASD).


Please send responses to iacc@mail.nih.gov no later than January 4, 2008.


Keep in mind that research does not only refer to scientific studies on genetics, the environment, neuroscience, and the like: Research also refers to research about the delivery of services and treatments. Some commenters have pointed out, for instance, tha...</description>
            <author>Autism Vox</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1124278</comments>
            <pubDate>Tue, 01 Jan 2008 17:00:45 +0100</pubDate>
            <guid isPermaLink="false">1124278</guid>        </item>
        <item>
            <title>Steering Autism Research: A reprise</title>
            <link>http://www.medworm.com/index.php?rid=603683&amp;cid=t_230599_133_f&amp;fid=35083&amp;url=http%3A%2F%2Fautismdiva.blogspot.com%2F2007%2F05%2Fsteering-autism-research-reprise.html</link>
            <description>A few months ago, in January, Autism Diva asked readers:Would you like to have a voice in how the National Institutes of Health (NIH) - National Institute of Mental Health (NIMH) spends it's autism research dollars?Autism Diva then gave some instructions on how one could send comments to the Interagency Autism Coordinating Committee regarding the state of autism research, telling them in which direction one would like to see it steered.Autism Diva was reading Michelle Dawson's QT board posts this morning and found that Michelle had shared news that the NIMH had just released a document called Evaluating Progress on the IACC Autism Research Matrix which includes a compilation of the feedback and directions they received from members of the public regarding how folks think that autism resear...</description>
            <author>Autism Diva</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=603683</comments>
            <pubDate>Fri, 11 May 2007 06:56:00 +0100</pubDate>
            <guid isPermaLink="false">603683</guid>        </item>
    </channel>
</rss>

